Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Myelodysplastic Syndromes 75Leukemia, Myeloid, Acute 68Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35Myeloproliferative Disorders 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma, Non-Hodgkin 21Primary Myelofibrosis 17Leukemia, Myelomonocytic, Chronic 17Leukemia 14Hodgkin Disease 14Myelodysplastic-Myeloproliferative Diseases 11Polycythemia Vera 10Leukemia, Biphenotypic, Acute 10Histiocytosis, Langerhans-Cell 10Anemia, Refractory, with Excess of Blasts 10Sarcoma 9Neuroblastoma 9Leukemia, Lymphocytic, Chronic, B-Cell 9Glioma 9Wilms Tumor 8Rhabdoid Tumor 8Neuroectodermal Tumors, Primitive, Peripheral 8Multiple Myeloma 8Medulloblastoma 8Hepatoblastoma 8Ependymoma 8Blastic Plasmacytoid Dendritic Cell Neoplasm 8Blast Crisis 8Thrombocythemia, Essential 7Rhabdomyosarcoma 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphohistiocytosis, Hemophagocytic × Myeloid × 30 days × Clear all
NCT03827343 2026-06-05

Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer

National Institutes of Health Clinical Center (CC)

Active not recruiting
500 enrolled
Myeloid

Lymphohistiocytosis, Hemophagocytic, Macrophage Activation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡